Alimta Injection is indicated for treatment of pleural mesothelioma & non-small cell lung cancer. Pemetrexed is the active compound present in this injection and has chemical formula C20H21N5O6 with molar mass of 427.411 g/mol. This injection is administered via intravenous route with protein binding ability of about 81% and elimination half life of 3.5 hours. It is a chemotherapy medication which works by inhibiting enzymes that are responsible for synthesis of purine, pyrimidine, & thymidine. Alimta Injection is highly effective in nature and assures targeted mode of action with long term effectiveness. It is not known to cause adverse health effects if administered under prescription.
Cash in Advance (CID), Cash Advance (CA)
500 Per Month
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market
Other Products in 'Pharmaceutical Injection' You May Like